Semi-Annual Statement Of Income And Retained Earnings

KYORIN Pharmaceutical Co., Ltd. - Filing #7373032

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
1,144,000,000 JPY
777,000,000 JPY
Non-operating income
Non-operating income
313,000,000 JPY
447,000,000 JPY
Non-operating expenses
Non-operating expenses
70,000,000 JPY
53,000,000 JPY
Ordinary profit (loss)
1,387,000,000 JPY
1,171,000,000 JPY
Extraordinary income
Extraordinary income
969,000,000 JPY
1,319,000,000 JPY
Extraordinary losses
Extraordinary losses
8,000,000 JPY
678,000,000 JPY
Profit (loss) before income taxes
2,349,000,000 JPY
1,812,000,000 JPY
Profit (loss)
1,757,000,000 JPY
1,242,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.